查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800868

内分泌检测市场报告（按检测类型、技术、最终用途和地区）2025-2033

Endocrine Testing Market Report by Test Type, Technology, End Use, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2024年全球内分泌检测市场规模达120亿美元。展望未来， IMARC Group预计到2033年市场规模将达到211亿美元，2025-2033年期间的成长率（CAGR）为6.53%。

内分泌检查是指透过测量体内荷尔蒙水平和诊断荷尔蒙相关疾病的医疗程序。此检查有助于发现可能导致某些慢性疾病的荷尔蒙浓度失衡。这些疾病通常透过细针穿刺 (FNA)、超音波、电脑断层扫描 (CT)、磁振造影 (MRI)、正子摄影 (PET)、放射性碘扫描 (RAI) 和静脉取样进行检测。由此获得的检查结果有助于确定疾病的进展并监测患者接受治疗的效果。

肾上腺功能不全、库欣氏症、巨人症、甲状腺功能低下症和甲状腺功能亢进症等内分泌相关疾病的盛行率不断上升，是推动市场成长的关键因素之一。此外，人们的健康意识不断增强，对及时检测益处的认识也促进了市场的成长。定期检测可以最大限度地降低併发症或病情恶化的风险，尤其是在老年患者中。同时，老年人口的不断增长也是另一个重要的成长诱因。此外，由于冠状病毒 (COVID-19) 疫情的爆发，内分泌检测被广泛用于检测感染患者的高血糖。此外，配备生物感测器的创新易操作检测试剂盒的开发，方便用户使用且经济高效，也为市场带来了积极的前景。医疗中心、实验室和诊断中心也在使用技术先进的液相层析质谱 (LC-MS) 技术来提供高精度和准确的结果。预计医疗保健基础设施的改善等其他因素也将进一步推动市场发展。

本报告回答的关键问题：

  • 全球内分泌检测市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对全球内分泌检测市场有何影响？
  • 主要的区域市场有哪些？
  • 根据测试类型，市场区隔是怎么样的？
  • 基于技术的市场区隔是怎样的？
  • 根据最终用途，市场是如何分類的？
  • 该产业的价值链分为哪些阶段？
  • 该行业的主要驱动因素和挑战是什么？
  • 全球内分泌检测市场的结构是怎么样的？主要参与者是谁？
  • 产业竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球内分泌检测市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依测试类型

  • 甲状腺检查
  • 胰岛素测试
  • 人类绒毛膜促性腺激素检测
  • 催乳素测试
  • 黄体生成素测试
  • 孕酮测试
  • 其他的

第七章：市场区隔：依技术

  • 免疫测定
  • 串联质谱法
  • 感测器技术
  • 液相层析-质谱法
  • 其他的

第 8 章：市场区隔：最终用途别

  • 医院
  • 门诊护理中心
  • 临床实验室
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章：SWOT分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • BioMerieux SA
    • DiaSorin SpA
    • F. Hoffmann-La Roche AG (Roche Holding AG)
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Siemens Healthineers AG (Siemens Aktiengesellschaft)
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A2900

The global endocrine testing market size reached USD 12.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 21.1 Billion by 2033, exhibiting a growth rate (CAGR) of 6.53% during 2025-2033.

Endocrine testing refers to the medical procedures conducted to measure the hormonal levels in the body and the diagnosis of hormone-related disorders. The testing aids in detecting an imbalance in the concentrations of hormones that may lead to the development of certain chronic conditions. These disorders are usually tested by fine-needle aspiration (FNA), ultrasound, computerized tomography (CT), magnetic resonance imaging (MRI), positron emission test (PET), radioactive iodine scan (RAI) and venous sampling. The test results thus obtained can assist in determining the progression of the disorder and monitoring the effects of the treatment being provided to the patient.

The increasing prevalence of endocrine-related disorders, such as adrenal insufficiency, Cushing's disease, gigantism, hypothyroidism and hyperthyroidism, represents one of the key factors driving the growth of the market. Furthermore, the increasing health consciousness and awareness regarding the benefits of timely testing is providing a boost to the market growth. Periodic testing minimizes the risks of developing complications or aggravation of the disorder, especially in elderly patients. In line with this, the rising geriatric population is acting as another major growth-inducing factor. Moreover, due to the onset of the coronavirus (COVID-19) pandemic, endocrine testing is being widely used to detect hyperglycemia in infected patients. Additionally, the development of innovative easy-to-operate test kits equipped with biosensors that facilitate user-friendly and cost-effective home-based diagnosis is creating a positive outlook for the market. Healthcare centers, laboratories and diagnostic centers are also using technologically advanced liquid chromatography with mass spectrometry (LC-MS) techniques to provide highly precise and accurate results. Other factors, including improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

Breakup by Test Type:

  • Thyroid Test
  • Insulin Test
  • Human Chorionic Gonadotropin Test
  • Prolactin Test
  • Luteinizing Hormone Test
  • Progesterone Test
  • Others

Breakup by Technology:

  • Immunoassay
  • Tandem Mass Spectroscopy
  • Sensor Technology
  • LC-MS
  • Others

Breakup by End Use:

  • Hospitals
  • Ambulatory Care Centers
  • Clinical Laboratories
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioMerieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche AG (Roche Holding AG), Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens Aktiengesellschaft) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global endocrine testing market performed so far and how will it perform in the coming years ?
  • What has been the impact of COVID-19 on the global endocrine testing market ?
  • What are the key regional markets ?
  • What is the breakup of the market based on the test type ?
  • What is the breakup of the market based on the technology ?
  • What is the breakup of the market based on the end use ?
  • What are the various stages in the value chain of the industry ?
  • What are the key driving factors and challenges in the industry ?
  • What is the structure of the global endocrine testing market and who are the key players ?
  • What is the degree of competition in the industry ?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Endocrine Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Thyroid Test
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Insulin Test
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Human Chorionic Gonadotropin Test
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Prolactin Test
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Luteinizing Hormone Test
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Progesterone Test
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunoassay
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tandem Mass Spectroscopy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sensor Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 LC-MS
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinical Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BioMerieux SA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 DiaSorin S.p.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Laboratory Corporation of America Holdings
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Quest Diagnostics Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Siemens Healthineers AG (Siemens Aktiengesellschaft)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Endocrine Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Endocrine Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Endocrine Testing Market: Breakup by Test Type (in %), 2024
  • Figure 4: Global: Endocrine Testing Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Endocrine Testing Market: Breakup by End Use (in %), 2024
  • Figure 6: Global: Endocrine Testing Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Endocrine Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: Endocrine Testing (Thyroid Test) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Endocrine Testing (Thyroid Test) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Endocrine Testing (Insulin Test) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Endocrine Testing (Insulin Test) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Endocrine Testing (Prolactin Test) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Endocrine Testing (Prolactin Test) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Endocrine Testing (Luteinizing Hormone Test) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Endocrine Testing (Luteinizing Hormone Test) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Endocrine Testing (Progesterone Test) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Endocrine Testing (Progesterone Test) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Endocrine Testing (Other Test Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Endocrine Testing (Other Test Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Endocrine Testing (Immunoassay) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Endocrine Testing (Immunoassay) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Endocrine Testing (Sensor Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Endocrine Testing (Sensor Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Endocrine Testing (LC-MS) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Endocrine Testing (LC-MS) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Endocrine Testing (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Endocrine Testing (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Endocrine Testing (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Endocrine Testing (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Endocrine Testing (Ambulatory Care Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Endocrine Testing (Ambulatory Care Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Endocrine Testing (Clinical Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Endocrine Testing (Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Endocrine Testing (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Endocrine Testing (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia Pacific: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia Pacific: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Endocrine Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Global: Endocrine Testing Industry: SWOT Analysis
  • Figure 89: Global: Endocrine Testing Industry: Value Chain Analysis
  • Figure 90: Global: Endocrine Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Endocrine Testing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Endocrine Testing Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 3: Global: Endocrine Testing Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Endocrine Testing Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 5: Global: Endocrine Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Endocrine Testing Market Structure
  • Table 7: Global: Endocrine Testing Market: Key Players